Initiatives by Various Government Agencies and Animal Associations Bolster Sector

Global Veterinary Vaccines Market

Dublin, April 19, 2023 (WORLD NEWSWIRE) — The “Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) – Global Forecast to 2025” report has actually been contributed to ResearchAndMarkets.com’s offering.

The worldwide veterinary vaccines market is forecasted to reach USD 10.8 billion by 2027 from USD 8.1 billion in 2022, at a CAGR of 5.9% throughout the projection duration. In emerging nations such as India and China, the family pet insurance coverage market remains in the nascent phase.

The increasing non reusable earnings and increasing family pet expense are anticipated to increase the adoption of family pet insurance plan and support the veterinary health market.

Bovine vaccines section represented a bigger share of the animals vaccines market

In 2021, the bovine vaccines section represented a bigger share of the animals vaccines market. This section is likewise approximated to grow at a greater CAGR throughout the projection duration. Growth in this section can mainly be credited to the increasing need for meat and milk and increased awareness about the avoidance of illness in animals.

The recombinant vaccines will grow at the greatest CAGR throughout the projection duration

Based on innovation, recombinant vaccines will grow at the greatest CAGR throughout the projection duration. The significant benefits provided by recombinant vaccines consist of the absence of requirement for adjuvants and the stability provided by these vaccines that permits them to stay feasible at ambient temperature levels. Also, these vaccines are devoid of pathogen contamination, show no post-vaccination responses, and use greater safety

North America represented the second-largest share of the worldwide veterinary vaccines market

In 2021, North America represented a share of the worldwide veterinary vaccines market. The increasing animal population and growing animal illness occurrence, increasing awareness of veterinary vaccines, and the increasing need for animal items are the significant aspects that are anticipated to drive the development of the veterinary vaccines market in North America. In addition to the increasing health care expense, there has actually been a rise in the family pet medical insurance market.

Story continues

Market Dynamics

Drivers

• Growth in Companion Animal Population

• Rising Incidence of Zoonotic Diseases

• Initiatives by Various Government Agencies and Animal Associations

• Rising Demand for Animal-Derived Food Products

• Growing Demand for Pet Insurance and Rising Animal Health Expenditure

Restraints

Opportunities

Challenges

Key Attributes:

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Veterinary Vaccines Market, by Type
6.1 Introduction
6.2 Livestock Vaccines
6.2.1 Bovine Vaccines
6.2.1.1 Bovine Vaccines Segment to Dominate Market
6.2.2 Small Ruminant Vaccines
6.2.2.1 Small Ruminant Vaccines Segment to Register Lower Growth in Livestock Vaccines Market
6.3 Porcine Vaccines
6.3.1 Second-Largest Market During Forecast Period
6.4 Poultry Vaccines
6.4.1 Increased Production and Rearing of Poultry to Drive Market Growth
6.5 Companion Animal Vaccines
6.5.1 Canine Vaccines
6.5.1.1 Canine Vaccines Segment to Dominate Companion Animal Vaccines Market During Forecast Period
6.5.2 Feline Vaccines
6.5.2.1 Rising Prevalence of Zoonotic Diseases to Drive Demand for Feline Vaccines
6.6 Aquaculture Vaccines
6.6.1 Vaccination Plays Crucial Role in Commercial Fish Farming
6.7 Other Animal Vaccines

7 Veterinary Vaccines Market, by Disease
7.1 Introduction
7.2 Porcine Diseases
7.2.1 Porcine Circovirus Ii to Account for Largest Share of Porcine Vaccines Market
7.3 Poultry Diseases
7.3.1 Infectious Bronchitis Segment to Account for Largest Share of Poultry Vaccines Market
7.4 Livestock Diseases
7.4.1 Bovine Diseases
7.4.1.1 Foot-And-Mouth Disease Segment to Account for Largest Share of Bovine Vaccines Market
7.4.2 Small Ruminant Diseases
7.4.2.1 Clostridial Disease Segment to Account for Largest Share of Small Ruminant Vaccines Market
7.5 Companion Animal Diseases
7.5.1 Canine Diseases
7.5.1.1 Canine Rabies Segment to Account for Largest Share of Canine Vaccines Market
7.5.2 Feline Diseases
7.5.2.1 Feline Viral Rhinotracheitis Segment to Grow at Highest CAGR During Forecast Period
7.6 Aquaculture Diseases
7.6.1 Vaccines in Aquaculture Majorly Developed for Salmonids, Catfish, and Shrimp

8 Veterinary Vaccines Market, by Technology
8.1 Introduction
8.2 Live Attenuated Vaccines
8.2.1 Live Attenuated Vaccines Segment to Account for Largest Market Share During Forecast Period
8.3 Inactivated Vaccines
8.3.1 Rising Need to Develop Artificial Immunity Against Diseases from Non-Living Pathogens to Drive Growth
8.4 Toxoid Vaccines
8.4.1 Toxoid Vaccines Used When Bacterial Toxins Cause Illness
8.5 Recombinant Vaccines
8.5.1 Advantages Associated with Recombinant Vaccines to Drive Demand
8.6 Other Vaccines

9 Veterinary Vaccines Market, by Route of Administration
9.1 Introduction
9.2 Injectable Vaccines
9.2.1 Injectable Vaccines Segment to Dominate Market During Forecast Period
9.3 Oral Vaccines
9.3.1 Oral Vaccines Make Immunization Easier
9.4 Intranasal/Spray Vaccines
9.4.1 Low Cost of Intranasal/Spray Vaccines to Support Market Growth

10 Veterinary Vaccines Market, by Distribution Channel
10.1 Introduction
10.2 Veterinary Hospitals
10.2.1 Veterinary Hospitals Form Largest and Fastest-Growing End-User Segment in Market
10.3 Veterinary Clinics
10.3.1 Increasing Number of Private Clinical Practices to Support Market Growth
10.4 Retail Pharmacies
10.4.1 Easy Accessibility to Pharmaceuticals to Support Market Growth

11 Veterinary Vaccines Market, by Region

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned

• Aptimmune

• Biogenesis Bago

• Biovac

• Boehringer Ingelheim International GmbH

• Brilliant Bio Pharma

• Ceva Sante Animale

• China Animal Husbandry Group

• Elanco Animal Health

• Endovac Animal Health

• Hester Biosciences Limited

• Hipra

• Indian Immunologicals Ltd.

• Intas Pharmaceuticals

• Jinyu Bio-Technology

• Laboratoire Lcv

• Merck & Co. Inc.

• Neogen Corporation

• Ourofino Animal Health

• Phibro Animal Health Corporation

• Tianjin Ringpu Biotechnology Co. Ltd.

• Torigen Pharmaceuticals, Inc.

• Vaxxinova International Bv

• Verovaccines GmbH

• Virbac

• Zoetis, Inc.

For more info about this report go to https://www.researchandmarkets.com/r/x9qzvb

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for global marketing research reports and market information. We supply you with the latest information on global and local markets, essential markets, the leading business, brand-new items and the latest patterns.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900